Literature DB >> 15485618

Gestational trophoblastic neoplasia: the management of relapsing patients and other recent advances.

Naveed Sarwar1, Edward S Newlands, Michael J Seckl.   

Abstract

The treatment of gestational trophoblastic neoplasia (GTN) represents one of the modern success stories in cancer medicine. Early diagnosis, effective treatments, monitoring of response with a series of serum human chorionic gonadotropin levels, and centralized care have all contributed to this success. Nevertheless, some patients relapse after initial chemotherapy. This review discusses the routine management of GTN and how to treat relapsed disease.

Entities:  

Mesh：

Year:  2004        PMID： 15485618     DOI： 10.1007/s11912-004-0079-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  49 in total

Review 1.  Advances in the understanding of placental site trophoblastic tumor.

Authors:  Colleen M Feltmate; David R Genest; Donald P Goldstein; Ross S Berkowitz
Journal:  J Reprod Med       Date:  2002-05       Impact factor: 0.142

2.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

Authors:  I A McNeish; S Strickland; L Holden; G J S Rustin; M Foskett; M J Seckl; E S Newlands
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

3.  Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.

Authors:  W B Jones; J Schneider; F Shapiro; J L Lewis
Journal:  Gynecol Oncol       Date:  1996-04       Impact factor: 5.482

4.  Pulmonary embolism, pulmonary hypertension, and choriocarcinoma.

Authors:  M J Seckl; G J Rustin; E S Newlands; S J Gwyther; J Bomanji
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

5.  EMACO in high risk gestational trophoblast disease--the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia.

Authors:  M Quinn; J Murray; M Friedlander; S Steigrad; S Khoo; D Marsden; I Hammond; T Jobling
Journal:  Aust N Z J Obstet Gynaecol       Date:  1994-02       Impact factor: 2.100

6.  Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology.

Authors:  P A Jacobs; P A Hunt; J S Matsuura; C C Wilson; A E Szulman
Journal:  Br J Obstet Gynaecol       Date:  1982-04

Review 7.  Management of high-risk gestational trophoblastic disease.

Authors:  J R Lurain
Journal:  J Reprod Med       Date:  1998-01       Impact factor: 0.142

8.  Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.

Authors:  J S Kwon; L Elit; J Mazurka; F Moens; M L Schmuck
Journal:  Gynecol Oncol       Date:  2001-08       Impact factor: 5.482

9.  Methotrexate infusion in low-risk gestational trophoblastic disease.

Authors:  L C Wong; H Y Ngan; D K Cheng; T Y Ng
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

Review 10.  The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN).

Authors:  E S Newlands
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-12       Impact factor: 5.237
View more
  1 in total

1.  Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?

Authors:  T Powles; P Savage; D Short; A Young; C Pappin; M J Seckl
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.